+

WO1999050284A3 - Molecule d'acide nucleique codant des proteines influant sur le developpement osseux - Google Patents

Molecule d'acide nucleique codant des proteines influant sur le developpement osseux Download PDF

Info

Publication number
WO1999050284A3
WO1999050284A3 PCT/EP1999/002055 EP9902055W WO9950284A3 WO 1999050284 A3 WO1999050284 A3 WO 1999050284A3 EP 9902055 W EP9902055 W EP 9902055W WO 9950284 A3 WO9950284 A3 WO 9950284A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid molecules
bone development
influencing bone
code proteins
Prior art date
Application number
PCT/EP1999/002055
Other languages
German (de)
English (en)
Other versions
WO1999050284A2 (fr
Inventor
Andre Rosenthal
Andreas Rump
Jochen Hess
Thomas Aigner
Thomas Wirth
Original Assignee
Andre Rosenthal
Andreas Rump
Jochen Hess
Thomas Aigner
Thomas Wirth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andre Rosenthal, Andreas Rump, Jochen Hess, Thomas Aigner, Thomas Wirth filed Critical Andre Rosenthal
Priority to EP99913304A priority Critical patent/EP1066318A1/fr
Priority to AU31476/99A priority patent/AU3147699A/en
Publication of WO1999050284A2 publication Critical patent/WO1999050284A2/fr
Publication of WO1999050284A3 publication Critical patent/WO1999050284A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une molécule d'acide nucléique codant des protéines qui influent sur le développement osseux de mammifères, ainsi que les protéines ainsi codées, des anticorps et des compositions d'ordre pharmaceutique et diagnostique. L'invention concerne en outre des animaux transgéniques qui expriment les protéines décrites, ainsi que des animaux chez lesquels le gène correspondant est inactivé et qui présentent un allongement des os.
PCT/EP1999/002055 1998-03-27 1999-03-26 Molecule d'acide nucleique codant des proteines influant sur le developpement osseux WO1999050284A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99913304A EP1066318A1 (fr) 1998-03-27 1999-03-26 Molecule d'acide nucleique codant des proteines influant sur le developpement osseux
AU31476/99A AU3147699A (en) 1998-03-27 1999-03-26 Nucleic acid molecules which code proteins influencing bone development

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813799 1998-03-27
DE19813799.0 1998-03-27

Publications (2)

Publication Number Publication Date
WO1999050284A2 WO1999050284A2 (fr) 1999-10-07
WO1999050284A3 true WO1999050284A3 (fr) 2001-04-12

Family

ID=7862700

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/002055 WO1999050284A2 (fr) 1998-03-27 1999-03-26 Molecule d'acide nucleique codant des proteines influant sur le developpement osseux

Country Status (3)

Country Link
EP (1) EP1066318A1 (fr)
AU (1) AU3147699A (fr)
WO (1) WO1999050284A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1300418A1 (fr) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Régulation génétique par des oligopeptides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039767A1 (fr) * 1996-04-19 1997-10-30 Zymogenetics, Inc. Procedes permettant d'induire la formation osseuse
WO1998001468A1 (fr) * 1996-07-05 1998-01-15 University Of Rochester Proteines de chondrocytes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039767A1 (fr) * 1996-04-19 1997-10-30 Zymogenetics, Inc. Procedes permettant d'induire la formation osseuse
WO1998001468A1 (fr) * 1996-07-05 1998-01-15 University Of Rochester Proteines de chondrocytes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AMLING M. ET AL.: "Bcl-2 lies downstream of parathyroid hormone-related peptide in a signalling pathway that regulates chondrocyte maturation during skeletal development", JOURNAL OF CELL BIOLOGY, vol. 136, no. 1, 13 January 1997 (1997-01-13), pages 205 - 213, XP002118856 *
RUMP A. ET AL.: "Identification and characterization of LOBO, a gene responsible for the generation of extraordinary long bones in transgenic mice", JOURNAL OF MOLECULAR MEDICINE, vol. 76, no. 6, May 1998 (1998-05-01), pages pB37, XP002118855 *

Also Published As

Publication number Publication date
WO1999050284A2 (fr) 1999-10-07
AU3147699A (en) 1999-10-18
EP1066318A1 (fr) 2001-01-10

Similar Documents

Publication Publication Date Title
EP1067182A3 (fr) Proteine secretoire ou proteine de membrane
DK1100880T3 (da) Urat oxidase
WO1999038972A3 (fr) Genes humains et produits ii d'expression genique
WO1999033982A3 (fr) Genes humains et produits d'expression genique i
WO1999058675A3 (fr) Genes humains et produits d'expression genique v
WO2001073059A3 (fr) 38692 et 21117, nouvelles molecules de phosphatase a double specificite et leurs utilisations
WO2003038041A3 (fr) Mut-il-4: proteines, anticorps, compositions, procedes et utilisations
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO1999002704A3 (fr) Phosphatase a double specificite et procedes d'utilisation
DE69728897D1 (de) Saeugetierchemokine
WO2003057821A3 (fr) Proteines et anticorps mut-il-18 or mut-il-18r, compositions, procedes et utilisations
WO1999054349A3 (fr) Molecules d'acides nucleiques dermatophagoides, proteines et leurs utilisations
WO1999050284A3 (fr) Molecule d'acide nucleique codant des proteines influant sur le developpement osseux
WO2001092493A3 (fr) Nouvelles aminopeptidases humaines 21956 et 25856, et utilisations
WO2000018916A3 (fr) Genes humains et produits d'expression genique
AU2002350406A1 (en) Identification of ses-3 (spr-5) in c. elegans and the uses of the same
WO1999055885A3 (fr) Nouvelle serine protease apte au clivage selectif de la proteine de liaison du facteur de croissance insuline-like
WO2003063767A3 (fr) Proteines du vrs, anticorps, compositions, procedes et utilisations
ATE419350T1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc- 2
AU2002314193A1 (en) Identification of ses-1 and the uses of the same
WO2002063013A3 (fr) Nouveau gene de phosphatase acide
ATE323772T1 (de) Regulatorische sequenzen des humanen mcp-1 gens
WO2000018211A8 (fr) Gene cochleaire coch5b2 et ses utilisations
WO2003083071A3 (fr) Proteines derivees de l'immunoglobuline liees au diabete, compositions, methodes et utilisations relatives a ces proteines
WO2001049839A3 (fr) Procede d'expression genique et son utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999913304

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999913304

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09647377

Country of ref document: US

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1999913304

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载